Analysts positive on SNN's prospects, but downgrade Elekta
This article was originally published in Clinica
Executive Summary
UK orthopedic firm Smith & Nephew has had a boost after Goldman Sachs analysts upgraded its stock from “neutral” to “buy.” However, Swedish radiotherapy specialist Elekta didn’t fare so well, being downgraded from “buy” to “neutral.”